Genetic defects in the PTEN tumor suppressor gene are leading to the constitutive activation of the PI3K/Akt/mTOR pathway in T-ALL (78) and are associated with a poor outcome in pediatric T-ALL (79). The gene discussed is PTEN; the disease is acute lymphoblastic leukemia.